Skip to content
Sign in

LABU · ARCA · ETF

Direxion Daily S&P Biotech Bull 3X ETF (LABU) Price, Holdings & Fees

$949.51−1.31%−$12.60End-of-day price as of Oct 9, 2026

Direxion Daily S&P Biotech Bull 3X ETF (LABU) closed at $949.51 on Oct 9, 2026, down 1.31% from the previous close of $962.11.

Share price, past year

1Y +9.73%

52-week range $804.20 – $989.00. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$949.51
Sep 30, 2026$989.00
Aug 31, 2026$913.61
Jul 31, 2026$874.74
Jun 30, 2026$838.39
May 29, 2026$851.33
Apr 30, 2026$826.44
Mar 31, 2026$870.68
Feb 27, 2026$836.00
Jan 30, 2026$816.42
Dec 31, 2025$839.19
Nov 28, 2025$867.94
Oct 31, 2025$856.36

Key statistics

Expense ratio
—
Net assets
$494.4M
as of Jul 31, 2026
Holdings
163
as of Jul 31, 2026
52-week range
$804.20 – $989.00

Holdings

Direxion Daily S&P Biotech Bull 3X ETF held 163 investments worth $494.36M as of Jul 31, 2026. Its largest holding was DREYFUS, at 15.86% of the fund.

Direxion Daily S&P Biotech Bull 3X ETF largest holdings by share of net assets
#Holding% of fundValue
1DREYFUS15.86%$78.39M
2GOLDMAN FINANCIAL14.83%$73.30M
3N/A9.63%$47.60M
4N/A7.30%$36.07M
5GOLDMAN SACHS LIQ ES FD A5.35%$26.47M
6N/A4.85%$23.96M
7N/A3.87%$19.15M
8APOGEE THERAPEUTICS INC1.11%$5.47M
9ORUKA THERAPEUTICS INCORKA1.03%$5.09M
10DIANTHUS THERAPEUTICS INCDNTH0.96%$4.72M
11ERASCA INCERAS0.93%$4.58M
12TWIST BIOSCIENCE CORPTWST0.92%$4.56M
13KYMERA THERAPEUTICS INCKYMR0.90%$4.46M
14SPYRE THERAPEUTICS INCSYRE0.89%$4.42M
15REVOLUTION MEDICINES INCRVMD0.89%$4.39M
16CG ONCOLOGY INCCGON0.88%$4.37M
17PROTAGONIST THERAPEUTICS INCPTGX0.88%$4.36M
18PRAXIS PRECISION MEDICINES INC0.87%$4.32M
19REGENERON PHARMACEUTICALS INCREGN0.87%$4.28M
20COGENT BIOSCIENCES INCCOGT0.85%$4.19M
21NATERA INCNTRA0.84%$4.17M
22ARROWHEAD PHARMACEUTICALS INCARWR0.82%$4.04M
23TRAVERE THERAPEUTICS INCTVTX0.82%$4.04M
24ROIVANT SCIENCES LTDROIV0.81%$4.03M
25RELAY THERAPEUTICS INCRLAY0.81%$4.02M

Top 25 of 163 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Direxion Daily S&P Biotech Bull 3X ETF holdings by asset type
Asset type% of fund
Stocks67.07%
Cash and short-term investments36.04%
Other derivatives26.32%
Direxion Daily S&P Biotech Bull 3X ETF holdings by country, largest 8
Country% of fund
United States125.79%
Ireland0.84%
Bermuda0.81%
Netherlands0.72%
Switzerland0.66%
British Virgin Islands0.35%
Cayman Islands0.14%
Canada0.11%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jul 31, 2026, Direxion Daily S&P Biotech Bull 3X ETF's total return was +28.14%, as reported to the SEC.

Direxion Daily S&P Biotech Bull 3X ETF monthly total returns
MonthTotal return
Jul 31, 2026−22.03%
Jun 30, 2026+49.27%
May 31, 2026+10.10%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Direxion Daily S&P Biotech Bull 3X ETF
Ticker
LABU
Exchange
ARCA
Fund type
ETF
Trust
Direxion Shares ETF Trust
SEC series ID
S000049373
SEC CIK
0001424958
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Direxion Shares ETF Trust, the trust behind Direxion Daily S&P Biotech Bull 3X ETF, and cover all of its funds.

Frequently asked questions

What is LABU's price?

Direxion Daily S&P Biotech Bull 3X ETF (LABU) closed at $949.51 on Oct 9, 2026, down 1.31% from the previous close of $962.11.

What does LABU hold?

Direxion Daily S&P Biotech Bull 3X ETF held 163 investments worth $494.36M as of Jul 31, 2026. Its largest holding was DREYFUS, at 15.86% of the fund. Its five largest holdings were DREYFUS, GOLDMAN FINANCIAL, N/A, N/A, GOLDMAN SACHS LIQ ES FD A.

How has LABU performed?

Over the 3 months to Jul 31, 2026, Direxion Daily S&P Biotech Bull 3X ETF's total return was +28.14%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 28, 2026). Prices are generated sample data for development. Data sources and disclosures